Covid Medicine 2-DG Launched (E)
Taking a step further in the war against the novel corona virus, scientists at DRDO’s Institute of Nuclear Medicine and Allied Sciences have developed an indigenous anti-covid drug. The drug called 2DG is a derivative of Glucose, and will reduce the recovery time and oxygen dependency in COVID-19 patients by hampering the growth of the virus.. After satisfactory clinical trials the drug was approved by DCGI for emergency use.. and the union Defence Minister Rajnath Singh released the first batch of the drug in a ceremony.
